Great Basin Whooping Cough Test Gets CE Marking

May 16, 2017

NEW YORK (GenomeWeb) – Great Basin announced today that its Bordetella Direct assay has received CE Marking.

The PCR-based test to detect Bordetella pertussis was granted 510(k) clearance by the US Food and Drug Administration earlier this year and will now be launched commercially.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Great Basin Whooping Cough Test Gets CE Marking

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

Featured White Papers

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

What's Popular?

NIH Funds $33M in COVID-19 Testing Projects for Safe Return of Students, Staff to School

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Sponsorships